ATP2B4 and melanoma: In addition, five RASGRF2 fusions have been identified in melanoma and melanocytic proliferations, including ATP2B4–RASGRF2 (n = 3) and ERBIN–RASGRF2 (n = 2), although no functional characterization of RASGRF2 fusions has been described22.